PATENT CLAIM ANALYSIS

Application Number: 15864496
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["424", "277100"]

Abstract:
Dendritic cells containing tumor lysate loaded particles are prepared. The dendritic cells present tumor antigens to elicit the Major Histocompatibility Complex class I pathway and can be used as a vaccine to treat cancer, including ocular melanoma.

Claim (Index 24):
The vaccine of  claim 23 , wherein the tumor lysate loaded particle is phagocytosed by the dendritic cell.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 86.0
- Lexical Diversity: 1.11111
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14019025', '15656067', '15123479', '13665145', '14248908']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7416993647726225
- 35 USC 102 Novelty (BERT): 0.5646749573387038
- Combined Prediction Score: 0.7239969240292307
- Mean Citation Score: 360.82611000000014
- Max Citation Score: 450.60153
- Similarity Product: 326.7995948071307

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test